4.07
price up icon0.99%   0.04
after-market After Hours: 4.07
loading
Scpharmaceuticals Inc stock is traded at $4.07, with a volume of 94,078. It is up +0.99% in the last 24 hours and down -4.91% over the past month. scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.
See More
Previous Close:
$4.03
Open:
$4.02
24h Volume:
94,078
Relative Volume:
0.31
Market Cap:
$203.12M
Revenue:
$17.63M
Net Income/Loss:
$-57.71M
P/E Ratio:
-3.0602
EPS:
-1.33
Net Cash Flow:
$-60.45M
1W Performance:
-8.13%
1M Performance:
-4.91%
6M Performance:
-12.66%
1Y Performance:
-24.07%
1-Day Range:
Value
$4.02
$4.08
1-Week Range:
Value
$4.00
$4.60
52-Week Range:
Value
$3.24
$6.71

Scpharmaceuticals Inc Stock (SCPH) Company Profile

Name
Name
Scpharmaceuticals Inc
Name
Phone
617-517-0730
Name
Address
25 BURLINGTON MALL ROAD, SUITE 203, BURLINGTON, MA
Name
Employee
96
Name
Twitter
@scPharmaUSA
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
SCPH's Discussions on Twitter

Scpharmaceuticals Inc Stock (SCPH) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-01-22 Initiated Cowen Outperform
Oct-21-22 Resumed Jefferies Buy
Oct-11-22 Upgrade SVB Leerink Mkt Perform → Outperform
Aug-02-22 Initiated Maxim Group Buy
Sep-09-21 Initiated SVB Leerink Mkt Perform
Oct-15-19 Initiated H.C. Wainwright Buy
Jan-30-19 Downgrade Leerink Partners Outperform → Mkt Perform
View All

Scpharmaceuticals Inc Stock (SCPH) Latest News

pulisher
Nov 02, 2024

scPharmaceuticals Inc. (NASDAQ:SCPH) Shares Acquired by Rice Hall James & Associates LLC - MarketBeat

Nov 02, 2024
pulisher
Nov 01, 2024

KING LUTHER CAPITAL MANAGEMENT CORP Expands Stake in scPharmaceu - GuruFocus.com

Nov 01, 2024
pulisher
Oct 23, 2024

TD Cowen reiterates Buy rating on scPharmaceuticals stock, highlights optimism for Furoscix approval - Investing.com India

Oct 23, 2024
pulisher
Oct 23, 2024

TD Cowen reiterates Buy rating on scPharmaceuticals stock, highlights optimism for Furoscix approval By Investing.com - Investing.com South Africa

Oct 23, 2024
pulisher
Oct 21, 2024

Third Time's The Charm For ScPharma? - RTTNews

Oct 21, 2024
pulisher
Oct 15, 2024

scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024 - GlobeNewswire

Oct 15, 2024
pulisher
Oct 15, 2024

Congestive Heart Failure Treatment Market 2034: Clinical - openPR

Oct 15, 2024
pulisher
Oct 09, 2024

The Attractiveness of Investing In scPharmaceuticals Inc (SCPH) is Growing - Knox Daily

Oct 09, 2024
pulisher
Oct 09, 2024

Daily Progress: scPharmaceuticals Inc (SCPH) Drop -2.33, Closing at 3.97 - The Dwinnex

Oct 09, 2024
pulisher
Oct 08, 2024

scPharmaceuticals GAAP EPS of -$0.41 misses by $0.05, revenue of $3.8M beats by $0.38M - MSN

Oct 08, 2024
pulisher
Oct 07, 2024

Does scPharmaceuticals (SCPH) Have the Potential to Rally 291.9% as Wall Street Analysts Expect? - MSN

Oct 07, 2024
pulisher
Oct 05, 2024

351,806 Shares in scPharmaceuticals Inc. (NASDAQ:SCPH) Acquired by Bank of Montreal Can - MarketBeat

Oct 05, 2024
pulisher
Sep 28, 2024

scPharmaceuticals Inc. (NASDAQ:SCPH) Short Interest Down 15.0% in September - MarketBeat

Sep 28, 2024
pulisher
Sep 23, 2024

Holdings of scPharmaceuticals Inc (SCPH) are aligned with the stars - SETE News

Sep 23, 2024
pulisher
Sep 23, 2024

Craig Hallum gives a Buy recommendation for scPharmaceuticals Inc (SCPH) - Knox Daily

Sep 23, 2024
pulisher
Sep 21, 2024

King Luther Capital Management Corp Purchases 752,005 Shares of scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat

Sep 21, 2024
pulisher
Sep 16, 2024

Investors in scPharmaceuticals (NASDAQ:SCPH) have unfortunately lost 23% over the last year - Yahoo Finance

Sep 16, 2024
pulisher
Sep 12, 2024

Rice Hall James & Associates LLC Has $2.16 Million Stock Holdings in scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat

Sep 12, 2024
pulisher
Sep 11, 2024

scPharmaceuticals Inc [SCPH] Investment Guide: What You Need to Know - Knox Daily

Sep 11, 2024
pulisher
Sep 09, 2024

scPharmaceuticals Inc. (NASDAQ:SCPH) Stock Holdings Increased by AIGH Capital Management LLC - MarketBeat

Sep 09, 2024
pulisher
Sep 05, 2024

scPharmaceuticals Inc [SCPH] 10% Owner makes an insider purchase of 500,000 shares worth 2.0 million. - Knox Daily

Sep 05, 2024
pulisher
Sep 04, 2024

scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com

Sep 04, 2024
pulisher
Sep 04, 2024

scPharmaceuticals’ $125 Million Senior Secured Term Loan - Global Legal Chronicle

Sep 04, 2024
pulisher
Sep 02, 2024

Do investors need to be concerned about scPharmaceuticals Inc (SCPH)? - US Post News

Sep 02, 2024
pulisher
Sep 02, 2024

There is no way scPharmaceuticals Inc (SCPH) can keep these numbers up - SETE News

Sep 02, 2024
pulisher
Sep 02, 2024

scPharmaceuticals Inc (SCPH) rating initates by Craig Hallum - Knox Daily

Sep 02, 2024
pulisher
Aug 25, 2024

Assenagon Asset Management S.A. Boosts Stake in scPharmaceuticals Inc. (NASDAQ:SCPH) - MarketBeat

Aug 25, 2024
pulisher
Aug 21, 2024

scPharmaceuticals Inc. to Post Q3 2024 Earnings of ($0.28) Per Share, HC Wainwright Forecasts (NASDAQ:SCPH) - MarketBeat

Aug 21, 2024
pulisher
Aug 21, 2024

Craig Hallum’s latest rating for SCPH stock - Knox Daily

Aug 21, 2024
pulisher
Aug 20, 2024

After losing 35% in the past year, scPharmaceuticals Inc. (NASDAQ:SCPH) institutional owners must be relieved by the recent gain - Yahoo Finance

Aug 20, 2024
pulisher
Aug 19, 2024

scPharmaceuticals (NASDAQ:SCPH) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Aug 19, 2024
pulisher
Aug 19, 2024

scPharmaceuticals stock rated a Buy amid revenue growth - Investing.com

Aug 19, 2024
pulisher
Aug 18, 2024

scPharmaceuticals (FRA:2SX) Inventory-to-Revenue : 1.54 (As of Jun. 2024) - GuruFocus.com

Aug 18, 2024
pulisher
Aug 16, 2024

Public Equity Report: AnaptysBio, Avidity draw nine-digit offerings - BioCentury

Aug 16, 2024
pulisher
Aug 16, 2024

scPharmaceuticals Second Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Aug 16, 2024
pulisher
Aug 15, 2024

Brokers Issue Forecasts for scPharmaceuticals Inc.'s Q2 2024 Earnings (NASDAQ:SCPH) - MarketBeat

Aug 15, 2024
pulisher
Aug 15, 2024

OrbiMed Advisors LLC buys $2 million in scPharmaceuticals stock By Investing.com - Investing.com South Africa

Aug 15, 2024
pulisher
Aug 15, 2024

OrbiMed Advisors LLC buys $2 million in scPharmaceuticals stock - Investing.com India

Aug 15, 2024
pulisher
Aug 15, 2024

Earnings call: scPharmaceuticals reports growth and label expansion By Investing.com - Investing.com Australia

Aug 15, 2024
pulisher
Aug 15, 2024

Earnings call: scPharmaceuticals reports growth and label expansion - Investing.com

Aug 15, 2024
pulisher
Aug 15, 2024

scPharmaceuticals Inc. (NASDAQ:SCPH) Q2 2024 Earnings Call Transcript - Insider Monkey

Aug 15, 2024
pulisher
Aug 15, 2024

Q2 2024 EPS Estimates for scPharmaceuticals Inc. (NASDAQ:SCPH) Decreased by Leerink Partnrs - Defense World

Aug 15, 2024
pulisher
Aug 15, 2024

scPharmaceuticals Inc (SCPH) Q2 2024 Earnings Call Transcript Hi - GuruFocus.com

Aug 15, 2024
pulisher
Aug 14, 2024

SCPH Stock Earnings: scPharmaceuticals Misses EPS, Misses Revenue for Q2 2024 - InvestorPlace

Aug 14, 2024
pulisher
Aug 14, 2024

scPharmaceuticals Inc Reports Q2 2024 Revenue of $8.1 Million, G - GuruFocus.com

Aug 14, 2024
pulisher
Aug 14, 2024

ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates - MSN

Aug 14, 2024
pulisher
Aug 14, 2024

scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update - GlobeNewswire

Aug 14, 2024
pulisher
Aug 14, 2024

Check Out scPharmaceuticals Inc (SCPH)’s Trade Data Rather Than the Analysts’ Views - SETE News

Aug 14, 2024
pulisher
Aug 14, 2024

A Tale of Resilience: scPharmaceuticals Inc Amid Stock Market Turbulence - The InvestChronicle

Aug 14, 2024
pulisher
Aug 13, 2024

Latham & Watkins Advises scPharmaceuticals on Growth Financings - Legal Desire News Network

Aug 13, 2024
pulisher
Aug 13, 2024

Watkins Advises scPharmaceuticals on Growth Financings - ILW.com

Aug 13, 2024

Scpharmaceuticals Inc Stock (SCPH) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Cap:     |  Volume (24h):